Related Experiment Videos
Anabolic effects of progestogens in bone remodelling
1IIIrd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Sbornik Lekarsky
|January 1, 1995
Summary
Norethisterone and tibolone reduce bone turnover markers similarly to estradiol in post-ovariectomy women. These treatments may act as bone-trophic hormones, preserving bone mass.
Area of Science:
- Endocrinology
- Bone Metabolism
- Pharmacology
Background:
- Estrogen deficiency after ovariectomy accelerates bone turnover.
- Understanding interventions to mitigate bone loss is crucial.
Purpose of the Study:
- To investigate the short-term effects of norethisterone and tibolone on bone turnover.
- To compare these effects with estradiol treatment.
Main Methods:
- Studied 49 women post-hysterectomy with bilateral ovariectomy.
- Measured biochemical indices of bone turnover, including urinary hydroxyproline excretion and bone isoenzyme of serum alkaline phosphatase.
- Assessed changes in bone mass.
Main Results:
- Norethisterone and tibolone significantly reduced urinary hydroxyproline excretion, similar to estradiol.
- Bone isoenzyme of serum alkaline phosphatase activity did not decrease with norethisterone or tibolone.
- Bone mass remained increased during norethisterone and tibolone treatments.
Conclusions:
- Norethisterone and tibolone demonstrate bone-protective effects.
- These agents may function as bone-trophic hormones, counteracting estrogen deficiency-induced bone loss.